The Boehringer Ingelheim Pharmaceuticals, Inc. owner is known worldwide for his trademarks. These brands are in demand in services such as For: Printed media, namely, brochures, pamphlets and stickers about COPD International Class(es): 016- Primary Class U.S Class(es): 002,005,022,023,029,037,038,050 Class Status: ACTIVE Basis: 1(a) First Use: Nov. 2009 Use in Commerce: Nov. 2009 For: Prov, For: Promoting public awareness of atrial fibrillation, its causes and treatment, and factors affecting stroke risk International Class(es): 035- Primary Class U.S Class(es): 100,101,102 Class Status: ACTIVE Basis: 1(a) First Use: Sep. 23, 2010 Use in Com, For: Promoting public awareness of transient ischemic attack, its risk factors and prevention International Class(es): 035- Primary Class U.S Class(es): 100,101,102 Class Status: ACTIVE Basis: 1(b) For: Providing medical information about transient ische, For: Providing health or medical information to patients, health care providers and care givers, focusing on issues relevant to treatment of patients living with HIV International Class(es): 044- Primary Class U.S Class(es): 100,101 Class Status: ACTIVE B, For: pharmaceutical preparations for the treatment and/or alleviation of ulcers and gastrointestinal disorders International Class(es): 005- Primary Class U.S Class(es): 006,018,044,046,051,052 Class Status: ACTIVE Basis: 1(b). You can contact Boehringer Ingelheim Pharmaceuticals, Inc. from anywhere in the world by phone or email, which you will find on our service. Trademarks presented to you have been re-registered at different times. Key Publication Dates - Oct. 14, 2010, May 03, 2010, May 06, 2010, Jun. 11, 2010, May 04, 2010, Oct. 07, 2010.